Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
42.74
Dollar change
+0.05
Percentage change
0.12
%
IndexS&P 500 P/E- EPS (ttm)-0.45 Insider Own0.72% Shs Outstand507.63M Perf Week1.74%
Market Cap21.71B Forward P/E13.31 EPS next Y3.21 Insider Trans-1.73% Shs Float504.32M Perf Month2.84%
Income-226.00M PEG- EPS next Q0.61 Inst Own91.55% Short Float1.62% Perf Quarter10.55%
Sales14.95B P/S1.45 EPS this Y11.56% Inst Trans0.70% Short Ratio2.16 Perf Half Y14.49%
Book/sh16.55 P/B2.58 EPS next Y10.68% ROA-0.11% Short Interest8.18M Perf Year7.25%
Cash/sh6.30 P/C6.79 EPS next 5Y4.07% ROE-0.44% 52W Range31.01 - 50.21 Perf YTD10.55%
Dividend Est.1.22 (2.85%) P/FCF21.00 EPS past 5Y- ROI-1.13% 52W High-14.88% Beta0.62
Dividend TTM1.16 (2.71%) Quick Ratio1.04 Sales past 5Y6.04% Gross Margin36.67% 52W Low37.83% ATR (14)0.85
Dividend Ex-DateFeb 29, 2024 Current Ratio1.48 EPS Y/Y TTM90.76% Oper. Margin9.63% RSI (14)58.81 Volatility1.74% 2.00%
Employees60000 Debt/Eq1.71 Sales Y/Y TTM-1.09% Profit Margin-1.51% Recom2.47 Target Price44.67
Option/ShortYes / Yes LT Debt/Eq1.38 EPS Q/Q39.78% Payout- Rel Volume0.97 Prev Close42.69
Sales Surprise2.07% EPS Surprise1.80% Sales Q/Q-0.05% EarningsFeb 08 BMO Avg Volume3.79M Price42.74
SMA201.15% SMA504.65% SMA2007.19% Trades Volume3,694,328 Change0.12%
Date Action Analyst Rating Change Price Target Change
May-30-23Resumed Morgan Stanley Equal-Weight $45
Mar-29-23Initiated UBS Neutral $43
Jan-06-23Downgrade Morgan Stanley Overweight → Equal-Weight $55
Jan-05-23Downgrade Raymond James Outperform → Mkt Perform
Jan-03-23Downgrade BofA Securities Buy → Neutral $66 → $55
Dec-19-22Downgrade JP Morgan Overweight → Neutral $68 → $55
Dec-15-22Downgrade Deutsche Bank Buy → Hold $69 → $51
Dec-12-22Downgrade Citigroup Buy → Neutral $64 → $58
Oct-18-22Initiated Barclays Overweight $64
Oct-12-22Initiated Jefferies Hold $62
Today 03:24PM
Mar-27-24 09:00AM
Mar-26-24 05:00PM
Mar-14-24 03:57AM
Mar-13-24 08:21AM
11:50PM Loading…
Mar-06-24 11:50PM
Mar-05-24 05:00PM
10:07AM
Mar-04-24 06:19AM
Feb-29-24 04:15PM
Feb-23-24 05:43AM
Feb-21-24 07:07PM
04:00PM
Feb-17-24 03:32AM
Feb-15-24 07:41AM
02:18PM Loading…
Feb-13-24 02:18PM
Feb-12-24 06:15PM
Feb-09-24 05:03PM
10:43AM
12:31AM
12:14AM
Feb-08-24 12:06PM
11:05AM
09:30AM
08:40AM
08:27AM
07:50AM
07:38AM
07:15AM
Feb-05-24 09:16AM
08:52AM Loading…
08:52AM
Jan-04-24 04:15PM
Dec-22-23 09:00AM
Dec-15-23 10:45PM
01:28PM
Dec-14-23 08:00AM
08:00AM
07:42AM
Dec-13-23 04:30PM
Dec-11-23 07:58PM
04:22PM
09:00AM
Dec-04-23 08:00AM
Nov-28-23 09:00AM
Nov-22-23 04:01PM
Nov-14-23 04:30PM
10:03AM
Nov-07-23 08:00AM
Nov-06-23 08:30AM
Nov-04-23 01:24PM
Nov-03-23 01:12AM
12:37AM
Nov-02-23 10:30PM
03:02PM
10:56AM
09:04AM
08:47AM
07:35AM
07:15AM
07:11AM
Nov-01-23 06:27PM
07:46AM
Oct-30-23 11:40AM
08:18AM
Oct-24-23 02:18AM
Oct-23-23 09:15AM
Oct-18-23 10:57AM
03:00AM
Oct-16-23 11:36AM
09:00AM
Oct-11-23 06:49PM
03:57PM
03:38PM
12:03PM
11:52AM
11:33AM
10:45AM
Oct-03-23 09:00AM
Sep-29-23 06:01PM
Sep-21-23 06:55PM
Sep-19-23 04:15PM
Sep-12-23 08:43AM
Sep-07-23 01:44PM
07:00AM
Aug-31-23 12:32PM
Aug-29-23 04:15PM
Aug-24-23 08:30AM
Aug-22-23 04:15PM
10:02AM
Aug-21-23 05:00PM
Aug-14-23 07:02PM
Aug-11-23 10:28AM
Aug-05-23 08:10AM
Jul-31-23 10:24AM
09:59AM
Jul-27-23 11:32AM
11:28AM
10:13AM
09:30AM
09:05AM
Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, surgical hemostat and sealant products, surgical equipment, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. It operates through the following segments: Americas, Europe, Middle East and Africa (EMEA), Asia-Pacific (APAC), and Hillrom. The Americas, EMEA, and APAC segments offer a portfolio of essential healthcare products. The Hillrom segment provides digital and connected care solutions and collaboration tools, including smart bed systems, patient monitoring and diagnostic technologies, respiratory health devices, and equipment for the surgical space. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mason Jeanne KEVP, Chief HR OfficerMar 01 '24Option Exercise37.1764,4882,397,019206,778Mar 05 04:15 PM
Mason Jeanne KEVP, Chief HR OfficerMar 01 '24Sale40.6164,4882,618,858142,290Mar 05 04:15 PM